
GLP-3Reta10mgTriple Agonist
GLP-3Reta
Lyophilized powder · ≥ 98.5% purity
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, positioning it as a next-generation candidate in metabolic pathway research.
Select Size
Quantity
Research applications
- Triple incretin receptor pharmacology
- Energy expenditure and metabolism
- Next-generation metabolic candidates
Listed applications reflect published preclinical and in-vitro research contexts. Wella products are supplied strictly for laboratory research and are not intended for human or veterinary use.
Specifications
- Purity
- ≥ 98.5%
- Form
- Lyophilized powder
- Verification
- HPLC & mass-spec
- Use
- Research only
Shipping
Ships from the USA within 1–2 business days. Tracked domestic and international options available at checkout.
Storage
Lyophilized peptides are shelf-stable at room temperature for shipping. Store at –20 °C after receipt for long-term stability.
Compliance
For laboratory research use only. Not for human or veterinary use. Certificate of analysis available on request.
Need a certificate of analysis?
Lot-specific HPLC and mass-spec reports are available on request. Include the peptide name and lot number in your message.